This webinar, held on 22 April 2026, examined recent developments in pneumococcal conjugate vaccine (PCV) policy. The programme included:
- An overview of the updated WHO Position Paper on PCV (World Health Organization)
- A presentation on the Systematic review of evidence supporting PCV 1+1 schedules (Murdoch Children’s Research Institute)
- An analysis of pneumococcal disease trends following a switch to a 1+1 schedule, drawing on the UK experience (UK Health Security Agency)
- A discussion of PCV decision‑making within the Vaccine Prioritization and Optimization Process (VPOP) (UNICEF and World Health Organization)
